Aging and brain 5-lipoxygenase
Aging and brain 5-lipoxygenase
批准号:
7495002
负责人:
HARI MANEV
金额:
$25.23万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 2011-08-31
关键词:
AcetylationAgeAgingAgonistAlzheimer&aposs DiseaseAmyloid beta-Protein PrecursorAmyloidosisAppendixApplications GrantsArachidonate 5-LipoxygenaseAutopsyBindingBinding SitesBiological AssayBrainBrain PathologyBrain regionCell MaturationCpG IslandsCytosineDNA MethylationDataDeoxycytidineDevelopmentEnzymesEpigenetic ProcessFundingGene ExpressionGenesGlucocorticoidsGlutamate ReceptorHistone AcetylationHistone DeacetylaseHistonesHumanIn VitroIncidenceInflammatoryKnock-outLaboratory StudyMeasuresMethionineMethylationModificationMonozygotic TwinningMonozygotic twinsMusNerve DegenerationNeuraxisNeuronsNumbersPathologyPatternPharmaceutical PreparationsPlayPredisposing FactorPrevention therapyProceduresPromoter RegionsReceptor ActivationRegulationReportingResearchResearch PersonnelRoleSmall Interfering RNATFAP2A geneTechniquesTestingTg2576TimeTranscriptional ActivationTwin Multiple BirthUp-RegulationWorkage effectaging brainbasebrain tissuechromatin immunoprecipitationdemethylationdesignexcitotoxicityin vivoinhibitor/antagonistmouse modelneuropathologynovelpreventprogramspromoterreceptor for advanced glycation endproductsresearch studytranscription factorvalproate
中文摘要
描述(由申请人提供):表观遗传机制,包括DNA甲基化和组蛋白修饰深刻影响基因表达,也似乎在衰老中改变。更好地了解大脑中的这些机制可能会为治疗/预防与衰老相关的中枢神经系统病变提供新的靶点。在过去四年的资助中,该实验室的研究已经确定,大脑中5-脂氧合酶(5-LOX)的表达,一种炎症酶,在衰老过程中增加,受到谷氨酸受体激活和糖皮质激素的刺激,可能与神经退行性疾病有关,可能在阿尔茨海默病(AD)中。其他人已经表明,5-LOX敲除在阿尔茨海默病的小鼠模型Tg 2576小鼠中,并减少淀粉样变性。最近的初步数据表明,神经元5-LOX表达在5-LOX启动子中CpG岛的甲基化状态改变后增加(例如,通过低甲基化药物5-氮杂-2 ′-脱氧胞苷)或在改变组蛋白乙酰化后(例如,通过组蛋白脱乙酰酶-HDAC-抑制剂)。在这个建议中,我们假设,表观遗传机制改变了老化的脑神经元,并负责脑5-LOX表达的调节; 5-LOX表达是由5-LOX启动子甲基化降低和/或改变组蛋白乙酰化和甲基化在5-LOX基因。我们提出了以下三个具体的目标:1)在小鼠中研究衰老对a)脑DNMT 1和HDAC表达,B)脑区域特异性5-LOX启动子甲基化,和c)5-LOX相关的组蛋白乙酰化和甲基化的影响; 2)在原代神经元培养物中,测试细胞成熟/老化对神经元DNMT 1和HDAC表达、5-LOX启动子甲基化、和5-LOX相关的组蛋白乙酰化和甲基化;和3)使用原代神经元培养物,研究DNMT 1和HDAC抑制/敲低在5-LOX表达中的作用。这项资助提案中概述的研究旨在提供相关数据来支持我们的假设,即表观遗传神经元改变是一个假定的因素,使衰老的大脑倾向于显示5-LOX基因表达上调。拟议的实验可能会证实这一假设,即表观遗传机制参与脑老化。
英文摘要
DESCRIPTION (provided by applicant): Epigenetic mechanisms that include DNA methylation and histone modifications profoundly influence gene expression and also appear to be altered in aging. A better understanding of these mechanisms in the brain may point to novel targets for the therapy/prevention of aging-associated central nervous system pathologies. Over the last four years of funding, studies from this laboratory have established that the brain expression of 5-lipoxygenase (5-LOX), an inflammatory enzyme, increases during aging, is stimulated by glutamate receptor activation and by glucocorticoids, and might be associated with neurodegeneration, possibly in Alzheimer's disease (AD). Others have shown that 5-LOX knockout in a mouse model of Alzheimer's disease, the Tg2576 mouse, and decreases amyloidosis. Recent preliminary data indicate that neuronal 5-LOX expression increases following changes in the methylation state of CpG islands in 5-LOX promoter (e.g., by a hypomethylating drug 5-aza-2'-deoxycytidine) or after altered histone acetylation (e.g., by histone deacetylases - HDACs - inhibitors). In this proposal, we hypothesize that epigenetic mechanisms are altered in aging brain neurons and are responsible for the regulation of brain 5-LOX expression; 5-LOX expression is triggered by decreased methylation at the 5-LOX promoter and/or altered histone acetylation and methylation at the 5-LOX gene. We propose the following three specific AIMs: 1) Investigate in mice the effects of aging on a) brain DNMT1 and HDACs expression, b) brain region-specific 5-LOX promoter methylation, and c) 5-LOX-related histone acetylation and methylation; 2) In primary neuronal cultures, test the in-vitro effects of cell maturation/aging on neuronal DNMT1 and HDACs expression, 5-LOX promoter methylation, and 5-LOX-related histone acetylation and methylation; and 3) Using primary neuronal cultures, investigate the role of DNMT1 and HDACs inhibition/knockdown in 5-LOX expression. The research outlined in this grant proposal is designed to provide relevant data in support of our hypothesis that an epigenetic neuronal alteration is a putative factor that predisposes the aging brain to display an upregulated expression of the 5-LOX gene. The proposed experiments may corroborate the hypothesis that epigenetic mechanisms are involved in brain aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A role for 5-lipoxyegenase in cocaine's actions
-
批准号:7561691
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2008
-
负责人:HARI MANEV
-
依托单位:
A role for 5-lipoxyegenase in cocaine's actions
-
批准号:7356854
-
项目类别:
-
资助金额:$15.7万
-
财政年份:2008
-
负责人:HARI MANEV
-
依托单位:
Proposed Role for Neuronal Serotonin N-acetyltransferase
-
批准号:7009367
-
项目类别:
-
资助金额:$22.83万
-
财政年份:2002
-
负责人:HARI MANEV
-
依托单位:
Proposed Role for Neuronal Serotonin N-acetyltransferase
-
批准号:6697071
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2002
-
负责人:HARI MANEV
-
依托单位:
Proposed Role for Neuronal Serotonin N-acetyltransferase
-
批准号:6621076
-
项目类别:
-
资助金额:$27.28万
-
财政年份:2002
-
负责人:HARI MANEV
-
依托单位:
Proposed Role for Neuronal Serotonin N-acetyltransferase
-
批准号:6430338
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2002
-
负责人:HARI MANEV
-
依托单位:
Proposed Role for Neuronal Serotonin N-acetyltransferase
-
批准号:6845360
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2002
-
负责人:HARI MANEV
-
依托单位:
GHB and GABA-B Receptor in Drosophila
-
批准号:6523586
-
项目类别:
-
资助金额:$7.79万
-
财政年份:2001
-
负责人:HARI MANEV
-
依托单位:
GHB and GABA-B Receptor in Drosophila
-
批准号:6447208
-
项目类别:
-
资助金额:$7.79万
-
财政年份:2001
-
负责人:HARI MANEV
-
依托单位:
AGING AND NEURONAL 5 LIPOXYGENASE
-
批准号:2759410
-
项目类别:
-
资助金额:$16.91万
-
财政年份:1998
-
负责人:HARI MANEV
-
依托单位:
Aging and brain 5-lipoxygenase
-
批准号:7144064
-
项目类别:
-
资助金额:$25.75万
-
财政年份:1998
-
负责人:HARI MANEV
-
依托单位:
Aging and brain 5-lipoxygenase
-
批准号:7917237
-
项目类别:
-
资助金额:$24.98万
-
财政年份:1998
-
负责人:HARI MANEV
-
依托单位:
AGING AND NEURONAL 5 LIPOXYGENASE
-
批准号:6124243
-
项目类别:
-
资助金额:$16.53万
-
财政年份:1998
-
负责人:HARI MANEV
-
依托单位:
AGING AND NEURONAL 5 LIPOXYGENASE
-
批准号:6475613
-
项目类别:
-
资助金额:$17.21万
-
财政年份:1998
-
负责人:HARI MANEV
-
依托单位:
AGING AND NEURONAL 5 LIPOXYGENASE
-
批准号:6328639
-
项目类别:
-
资助金额:$16.67万
-
财政年份:1998
-
负责人:HARI MANEV
-
依托单位:
Aging and brain 5-lipoxygenase
-
批准号:7676006
-
项目类别:
-
资助金额:$25.23万
-
财政年份:1998
-
负责人:HARI MANEV
-
依托单位:
SIMILAR EFFECTS OF AGING AND PINEALECTOMY ON RAT BRAIN
-
批准号:2330244
-
项目类别:
-
资助金额:$6.45万
-
财政年份:1996
-
负责人:HARI MANEV
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: